International MedTech Company KARL STORZ Acquires King’s College London’s 3D Medical Modelling Spin-Out
Innersight Labs, a cutting-edge AI-powered medical software company spun-out from the School of Biomedical Engineering & Imaging Sciences at King’s College London, has been acquired by leading international MedTech company KARL STORZ.
Innersight Labs Ltd (ISL) specialises in using data from patient medical scans to create 3D imagery of internal organs and different tissue types.
Its Innersight3D software allows surgeons to create interactive 3D models that are patient-specific. These can be used to pre-plan for surgical procedures with more accurate information based on the patient’s own medical scans.
The virtual models can easily be used via mobile and desktop devices rather than requiring specialist technology. This simplifies a surgeon’s planning, makes surgeries easier and improves patient outcomes.
In a study published in 2019, the use of pre-operative virtual 3D models was found to improve surgical decision-making in cases for partial nephrectomy – surgery that removes part of the kidney to treat suspected cancer. A change of surgical approach was reported in 19% of cases, while surgeons also reported increased confidence in their decisions.
Innersight’s technology helps surgeons plan before and during surgery on 3D models created specifically from a patient’s own anatomy. Our belief is that better surgical planning can improve surgical outcomes, reduce the risk of complications, and allow more patients to benefit from minimally invasive surgery, ultimately lowering provider costs.
Dr Eoin R. Hyde, Co-founder, Innersight Labs, and a former Enterprise Fellow at King’s College London
The exit of Innersight Labs to one of the most respected companies in the industry proves the success of our unique approach of translating medical device innovations from bench to bedside to boardroom. Having leveraged our MedTech hub’s end-to-end development, clinical translation and commercialisation resources, Innersight Labs leads the way in a pipeline of innovations from King’s that will make an impact on patients’ lives, globally. We are delighted that the Innersight founders are eager to give back to our unique ecosystem by advising our newer generations of MedTech entrepreneurs at our flagship London Institute for Healthcare Engineering (LIHE).
Professor Sebastien Ourselin FReng FMedSci; Director, LIHE; Head of the School of Biomedical Engineering & Imaging Sciences
We want to continue pioneering MedTech, particularly in the areas of software and robotics. The research background that ISL brings to the table therefore fits ideally with our vision, mission, and strategic goals. We warmly welcome them to the KARL STORZ family.
Thorsten Molitor, Executive Vice President, KARL STORZ
Innersight Labs currently employs eight people and also operates an office in India. Due to the strong historical links of the company with King’s, members of the Innersight team will be based at the newly opening London Institute for Healthcare Engineering (LIHE).
LIHE at King’s College London brings together world-class research and development expertise across academia, the NHS and MedTech companies all co-located within a landmark building overlooking the Thames and embedded within the St Thomas’ Hospital campus.
Dr Nicolas Huber, Director, Commercial Operations and Partnerships (LIHE), added:
“We’re delighted that Innersight Labs have chosen to continue their presence in King’s at LIHE, and to contribute to our MedTech hub by supporting the new generation of innovations from King’s. LIHE is uniquely positioned to bring together King’s research excellence, GSTT’s leading clinical practice and the MedTech sector’s commercial innovation power and talent, while simultaneously providing physical space in the heart of London to start-ups, SMEs and multinationals.”
